We currently demonstrate that combined therapy of either the NE inhibitor SIVE or the PAD4 inhibitor Cl-Amidine with Fn14 mAb synergistically provides protection against AKI in distinct murine models of sepsis. The gene discussed is PADI4; the disease is Sepsis.